GS

Garden State Life Sciences Venture

North America, Pennsylvania, United States, Philadelphia

Description

Garden State Life Sciences Venture is a venture capital firm.

Investor Profile

Garden State Life Sciences Venture has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series C (67%)
  • Series D (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Garden State Life Sciences Venture frequently co-invest with?

Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 1
Radius Ventures
North America, New York, United States, New York
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
CHL Medical Partners
North America, Connecticut, United States, Stamford
Co-Investments: 1
NewSpring
North America, Pennsylvania, United States, Radnor
Co-Investments: 2
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 1
Palo Alto Investors
North America, California, United States, Palo Alto
Co-Investments: 1
Quaker BioVentures
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 3
Prospect Venture Partners
North America, California, United States, Palo Alto
Co-Investments: 1
EE
North America, New Jersey, United States, Bedminster
Co-Investments: 2

What are some of recent deals done by Garden State Life Sciences Venture?

EKR Therapeutics

Bedminster, New Jersey, United States

EKR Therapeutics provides a segment of the healthcare market with products to improve patient outcomes and quality of life.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series DMar 10, 2008
Amount Raised: $50,000,000
EKR Therapeutics

Bedminster, New Jersey, United States

EKR Therapeutics provides a segment of the healthcare market with products to improve patient outcomes and quality of life.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CAug 15, 2007
Amount Raised: $13,000,000
Amicus Therapeutics

Cranbury, New Jersey, United States

Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CSep 8, 2005
Amount Raised: $55,000,000